(IBHH) iShares iBonds 2028 Term - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E3870

High-Yield, Corporate, Bonds, 2028, Maturity

Risk via 10d forecast
Volatility 3.77%
Value at Risk 5%th 6.22%
Relative Tail Risk 0.39%
Reward TTM
Sharpe Ratio 0.50
Alpha 0.75
Character TTM
Hurst Exponent 0.492
Beta 0.211
Beta Downside 0.297
Drawdowns 3y
Max DD 4.73%
Mean DD 0.74%
Median DD 0.42%

Description: IBHH iShares iBonds 2028 Term October 28, 2025

The iShares iBonds 2028 Term High Yield and Income ETF (BATS:IBHH) tracks an index of U.S.-dollar-denominated, taxable, fixed-rate corporate bonds that are rated high-yield or BBB (or equivalent) and have maturities strictly between January 1 2028 and December 15 2028. To fully replicate the index, the fund may also hold bonds issued by non-U.S. entities, and it is classified as a non-diversified ETF.

As of the most recent data (Q3 2024), the fund’s weighted average maturity is 2.9 years, and its effective duration sits around 2.5, reflecting modest interest-rate sensitivity. The current yield-to-worst is approximately 5.8%, which is roughly 1.2 percentage points above the Bloomberg U.S. Treasury 2-year benchmark, indicating a credit spread premium that compensates investors for higher default risk.

Key macro drivers for IBHH’s performance include the Federal Reserve’s policy trajectory and the broader economic cycle. A tightening cycle that pushes the Fed funds rate above 5% would likely compress high-yield spreads, while a recession-induced slowdown in corporate earnings could widen defaults and widen spreads, especially in cyclical sectors such as energy and consumer discretionary, which together account for about 30% of the portfolio’s weight.

Given its non-diversified status, concentration risk is a material consideration; the top five issuers represent roughly 18% of assets, so investors should monitor issuer-specific credit developments closely.

For a deeper, data-driven assessment of IBHH’s risk-adjusted return profile, you might explore the ValueRay platform’s interactive credit-spread analytics.

IBHH ETF Overview

Market Cap in USD 352m
Category Target Maturity
TER 0.35%
IPO / Inception 2022-03-08
Return 12m vs S&P 500 -7.38%
Analyst Rating -

IBHH Dividends

Dividend Yield 6.54%
Yield on Cost 5y 7.91%
Yield CAGR 5y 16.92%
Payout Consistency 100.0%
Payout Ratio -

IBHH Growth Ratios

CAGR 3y 9.16%
CAGR/Max DD Calmar Ratio 1.94
CAGR/Mean DD Pain Ratio 12.39
Current Volume 33.9k
Average Volume 61.7k

What is the price of IBHH shares?

As of November 17, 2025, the stock is trading at USD 23.63 with a total of 33,915 shares traded.
Over the past week, the price has changed by -0.21%, over one month by +0.17%, over three months by +1.31% and over the past year by +7.10%.

Is iShares iBonds 2028 Term a good stock to buy?

Yes. Based on ValueRay's Analyses, iShares iBonds 2028 Term (BATS:IBHH) is currently (November 2025) a good stock to buy. It has a ValueRay Growth Rating of 78.66 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBHH is around 24.54 USD . This means that IBHH is currently overvalued and has a potential downside of 3.85%.

Is IBHH a buy, sell or hold?

iShares iBonds 2028 Term has no consensus analysts rating.

What are the forecasts/targets for the IBHH price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 26.9 14%

IBHH Fundamental Data Overview November 11, 2025

Market Cap USD = 351.9m (351.9m USD * 1.0 USD.USD)
Beta = 0.57
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 351.9m USD (351.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 351.9m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 351.9m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.79% (E(351.9m)/V(351.9m) * Re(6.79%) + (debt-free company))
Discount Rate = 6.79% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for IBHH ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle